US 11174219
Neprilysin inhibitors
granted A61KA61K31/41A61K31/415
Quick answer
US patent 11174219 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/41, A61K31/415, A61K31/4155, A61K31/4192